Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of cultured neuronal cells

Growth Hormone and IGF Research

Volumn 17, Issue 4, 2007, Pages 315-322

  Lyuh, Esther ^a   Kim, Hyun Jung ^a   Kim, Manho ^a   Lee, Jung Kwon ^b   Park, Kyong Soo ^a   Yoo, Keun Young ^a   Lee, Kwang Woo ^a   Ahn, Yoon Ok ^a  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Differentiation; Extracellular receptor kinase (ERK); Growth hormone; Neuronal cells; Proliferation

Indexed keywords

CASPASE 3; HOE 33342; HUMAN GROWTH HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; IN VITRO STUDY; MOTONEURON; MOUSE; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; GROWTH HORMONE; MAP KINASE SIGNALING SYSTEM; NEURONS; RATS;

EID: 34547179806     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.03.002     Document Type: Article

References (54)

1. Lamberts S.W., van den Beld A.W., and van der Lely A.J. The endocrinology of aging. Science 278 (1997) 419-424
2. Urban R.J. Neuroendocrinology of aging in the male and female. Endocrinol. Metab. Clin. North Am. 21 (1992) 921-931
3. Martin F.C., Yeo A.L., and Sonksen P.H. Growth hormone secretion in the elderly: ageing and the somatopause. Baillieres Clin. Endocrinol. Metab. 11 (1997) 223-250
4. Toogood A.A., O'Neill P.A., and Shalet S.M. Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. J. Clin. Endocrinol. Metab. 81 (1996) 460-465
5. Harman S.M., and Blackman M.R. Use of growth hormone for prevention or treatment of effects of aging. J. Gerontol. A Biol. Sci. Med. Sci. 59 (2004) 652-658
6. Lee K.O., Liao L., and Mukherjee J.J. Does growth hormone prevent aging in the healthy elderly with low serum insulin-like growth factor-I?. Mech. Ageing Dev. 125 (2004) 291-295
7. Cummings D.E., and Merriam G.R. Age-related changes in growth hormone secretion: should the somatopause be treated?. Semin. Reprod. Endocrinol. 17 (1999) 311-325
8. Savine R., and Sonksen P. Growth hormone - hormone replacement for the somatopause?. Horm. Res. 53 Suppl. 3 (2000) 37-41
9. Savine R., and Sonksen P.H. Is the somatopause an indication for growth hormone replacement?. J. Endocrinol. Invest. 22 (1999) 142-149
10. Moller N., Gjedsted J., Gormsen L., Fuglsang J., and Djurhuus C. Effects of growth hormone on lipid metabolism in humans. Growth Horm. IGF Res. 13 Suppl. A (2003) S18-S21
11. Zamenhof S. Stimulation of the proliferation of neurons by the growth hormone: I. Experiments on tadpoles. Growth 5 (1941) 123-139
12. Frago L.M., Paneda C., Dickson S.L., Hewson A.K., Argente J., and Chowen J.A. Growth hormone (GH) and HG-releasing peptide-6 increase brain insulin-like growth factor-1 expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology 143 (2002) 4113-4122
13. Wilczak N., and de Keyser J. Insulin like growth factor system in amyotrophic lateral sclerosis. Endocr. Dev. 9 (2005) 160-169
14. Dobrowolny G., Giacinti C., Pelosi L., Pelosi L., Nicoletti C., Winn N., Barberi L., Molinaro M., Rosenthal N., and Musaro A. Muscle expression of a local IGF-1 isoform protects motor neurons in ALS mouse model. J. Cell Biol. 168 (2005) 193-199
15. Scheepens A., Sirimanne E.S., Breier B.H., Clark R.G., Gluckman P.D., and Williams C.E. Growth hormone as a neuronal rescue factor during recovery from CNS injury. Neuroscience 104 (2001) 677-687
16. Winkler T., Sharma H.S., Stalberg E., Badgaiyan R.D., Westman J., and Nyberg F. Growth hormone attenuates alterations in spinal cord evoked potentials and cell injury following trauma to the rat spinal cord. An experimental study using topical application of rat growth hormone. Amino Acids 19 (2000) 363-371
17. Hanci M., Kuday C., and Oguzoglu S.A. The effects of synthetic growth hormone on spinal cord injury. J. Neurosurg. Sci. 38 (1994) 43-49
18. Chen L., Lund P.K., Burgess S.B., Rudisch B.E., and McIlwain D.L. Growth hormone, insulin like growth factor-1 and motor neuron size. J. Neurobiol. 32 (1997) 202-212
19. Parsons S.A., Banks G.B., Rowland J.A., Coschigano K.T., Kopchick J.J., Waters M.J., and Noakes P.G. Genetic disruption of the growth hormone receptor does not influence motoneuron survival in the developing mouse. Int. J. Dev. Biol. 47 (2003) 41-49
20. Boillee S., and Cleveland D.W. Gene therapy for ALS delivers. Trends Neurosci. 27 (2005) 235-238
21. Bilic E., Rudan I., Kisec V., Zurak N., Delimar D., and Zagar M. Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls. Eur. J. Neurol. 13 (2006) 1340-1345
22. Dolcet X., Soler R.M., Gould T.W., Egea J., Oppenheim R.W., and Comella J.X. Cytokines promote motoneuron survival through the Janus kinase-dependent activation of the phosphatidylinositol 3-kinase pathway. Mol. Cell Neurosci. 18 (2005) 619-631
23. Argetsinger L.S., Campbell G.S., Yang X., Witthuhn B.A., Silvennoinen O., Ihle J.N., and Carter-Su C. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74 (1993) 237-244
24. Herrington J., Smit L.S., Schwartz J., and Carter-Su C. The role of STAT proteins in growth hormone signaling. Oncogene 19 (2000) 2585-2597
25. Smit L.S., Meyer D.J., Billestrup N., Norstedt G., Schwartz J., and Carter-Su C. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Mol. Endocrinol. 10 (1996) 519-533
26. Buckley S., Driscoll B., Weinberg L., Anderson K., and Warburton D. ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2. Am. J. Physiol. 277 (1999) 159-166
27. Erhardt P., Schremser E.J., and Cooper G.M. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/ERK pathway. Mol. Cell Biol. 19 (1999) 5308-5315
28. Wang X., Martindale J.L., Liu Y., and Holbrook N.J. The cellular response to oxidative stress: Influences of mitogen-activated protein kinases signalling pathways on cell survival. Biochem. J. 333 (1998) 291-300
29. Anderson C.N.G., and Tolkovsky A.M. A role for MAPK/ERK in sympathetic neuron survival: Protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. J. Neurosci. 19 (1999) 664-673
30. Smith R.G., Alexianu M.E., Crawford G., Nyormoi O., Stefani E., and Appel S.H. The cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc. Natl. Acad. Sci. USA 91 (1994) 3393-3397
31. LaBella V., Alexianu M.E., Colom L.V., Ionescu A., Mohamed A.H., and Appel S.H. Apoptosis induced by b-N-oxalylamino-l-alanine on a motoneuron hybrid cell line. Neuroscience 70 (1996) 1039-1052
32. Smith R.G., and Appel S.H. Extracts of skeletal muscle increase neurite outgrowth and cholinergic activity of fetal rat spinal motor neurons. Science 219 (1983) 1079-1081
33. Bromberg J.F. Activation of STAT proteins and growth control. Bioessays 23 (2001) 161-169
34. Chen L., Lund P.K., Burgess S.B., Rudisch B.E., and McIlwain D.L. Growth hormone, insulin like growth factor-1 and motor neuron size. J. Neurobiol. 32 (1997) 202-212
35. Carter-Su C., and Smit L.S. Signaling via JAK tyrosine kinases: growth hormone receptor as a model system. Rec. Prog. Horm. Res. 53 (1998) 61-82 discussion 82-63
36. Han Y., Leaman D.W., Watling D., Rogers N.C., Groner B., Kerr I.M., Wood W.I., and Stark G.R. Participation of JAK and STAT proteins in growth hormone-induced signaling. J. Biol. Chem. 271 (1996) 5947-5952
37. Hellgren G., Albertsson-Wikland K., Billig H., Carlsson L.M., and Carlsson B. Growth hormone receptor interaction with Jak proteins differs between tissues. J. Interferon Cytok. Res. 21 (2001) 75-83
38. Jeay S., Sonenshein G.E., Postel-Vinay M.C., Kelly P.A., and Baixeras E. Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways. Mol. Cell Endocrinol. 188 (2002) 1-7
39. Vernon R.G., and Lindsay-Watt S. Possible role for PI3 kinase but not p70S6K in regulation of lipogenesis by insulin and growth hormone in sheep adipose tissue. Biochem. Soc. Trans. 23 (1995) 190S
40. Yamauchi T., Kaburagi Y., Ueki K., Tsuji Y., Stark G.R., Kerr I.M., Tsushima T., Akanuma Y., Komuro I., Tobe K., Yazaki Y., and Kadowaki T. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase. J. Biol. Chem. 273 (1998) 15719-15726
41. Yamauchi T., Ueki K., Tobe K., Tamemoto H., Sekine N., Wada M., Honjo M., Takahashi M., Takahashi T., Hirai H., Tsushima T., Akanuma Y., Fujita T., Komuro I., Yazaki Y., and Kadowaki T. Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression. Endocrinol. J. 45 supplement (1998) S27-S31
42. Anderson N.G. Rapid activation of MAP kinase and S6 kinase by growth hormone in 3T3-F442A preadipocytes. Biochem. Soc. Trans. 20 (1992) 270S
43. Campbell G.S., Pang L., Miyasaka T., Saltiel A.R., and Carter-Su C. Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts. J. Biol. Chem. 267 (1992) 6074-6080
44. Ferrer I., and Planas A. Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J. Neuropathol. Exp. Neurol. 62 (2003) 329-339
45. Love S. Apoptosis and brain ischaemia. Prog. Neuropsychopharmacol., Biol. Psych. 27 (2003) 267-282
46. Morales O., Samuelsson M.K., Lindgren U., and Haldosen L.A. Effects of 1-α-2,5-dihydroxyvitamin D3 and growth hormone on apoptosis and proliferation in UMR 106 osteoblast-like cells. Endocrinology 145 (2004) 87-94
47. Turnley A.M., Faux C.H., Rietze R.L., Coonan J.R., and Bartlett P.F. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling. Nat. Neurosci. 5 (2002) 1155-1162
48. Moller N., and Norrelund H. The role of growth hormone in the regulation of protein metabolism with particular reference to conditions of fasting. Horm. Res. 59 Suppl 1 (2003) 62-68
49. Lee K.W., Kim H.J., Sung J.J., Park K.S., and Kim M. Defective neurite outgrowth in aphidicolin/cAMP-induced motor neurons expressing mutant Cu/Zn superoxide dismutase. Int. J. Dev. Neurosci. 20 (2002) 521-526
50. Perls T.T. Anti-aging quackery: human growth hormone and tricks of the trade-more dangerous than ever. J. Gerontol. A Biol. Sci. Med. Sci. 59 (2004) 682-691
51. Bartke A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 78 (2003) 210-216
52. Zhang X., Wang Y., Li Z., Leng J., Bai Q., Huang X., and Huang Y. Applied study on small-dose growth hormone supplement for aging-related symptom complex. Zhong. Nan Ke Xue 10 (2004) 601-603 607
53. Lasmezas C., Deslys J.P., and Dormont D. Recombinant human growth hormone and insulin-like growth factor I induce PRP gene expression in PC 12 cells. Biochem. Biophys. Res. Commun. 196 3 (1993) 1163-1169
54. Silva C., Zhang K., Tsutsui S., Holden J.K., Gill M.J., and Power C. Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression. Ann. Neurol. 54 5 (2003) 605-614